Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Lifshitz Law PLLC Announces Investigations of Cytokinetics, Incorporated (NASDAQ: CYTK), Fly-E Group, Inc. (NASDAQ: FLYE), Lantheus Holdings, Inc. (NASDAQ: LNTH), and Savara Inc. (NASDAQ: SVRA)

accessnewswire.com
CYTK Investigation announced into possible securities law violations and/or breaches of fiduciary duties regarding false/misleading statements about NDA submission timeline for aficamten. FLYE Investigation into allegations of false/misleading statements about revenue growth while minimizing risks related to lithium batteries, supply chain, and regulatory changes impacting e-vehicle sales. LNTH Investigation into allegations of creating a false impression of reliable revenue outlook and growth while downplaying risks from competition, pricing, seasonality, and macroeconomic factors. SVRA Investigation into allegations of failing to disclose issues with MOLBREEVI BLA's manufacturing and controls, making FDA approval unlikely and potentially requiring additional capital.

NEW YORK CITY, NY / ACCESS Newswire / December 5, 2025 / Cytokinetics, Incorporated (NASDAQ:CYTK)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information. Specifically, the Company allegedly made materially false and misleading statements regarding the timeline for the New Drug Application ("NDA") submission and approval process for aficamten.

If you are a CYTK investor, or possess relevant information and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Fly-E Group, Inc. (NASDAQ:FLYE)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information. Allegedly, the Company provided investors with material information concerning Fly-E's overall revenue growth from and anticipated sales of its E-bikes, E-motorcycles and E-scooters, while, at the same time, minimizing risks associated with Fly-E's lithium battery, supply chain changes, and regulatory changes which took a material toll on its E-vehicle sales revenue. The Company's forecasting processes fell short as the sales declined and operating expenses increased.

If you are a FLYE investor, or possess relevant information and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Lantheus Holdings, Inc. (NASDAQ:LNTH)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information. Specifically, the Company allegedly created the false impression that they possessed reliable information pertaining to the Company's projected revenue outlook and anticipated growth while also minimizing risk from competition and pricing dynamics, seasonality, and macroeconomic fluctuations. In truth, these optimistic reports fell short of reality.

If you are an LNTH investor, or possess relevant information and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Savara Inc. (NASDAQ:SVRA)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information. Specifically, the Company allegedly failed to disclose that: (1) the MOLBREEVI BLA lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls; (2) accordingly, the FDA was unlikely to approve the MOLBREEVI BLA in its current form; (3) the foregoing made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe that it had represented to investors; (iv) the delay in MOLBREEVI's regulatory approval increased the likelihood that the company would need to raise additional capital; (5) as a result, the Company's public statements were materially false and misleading.

If you are an SVRA investor, or possess relevant information and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2025 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: [email protected]

SOURCE: Lifshitz Law Firm